Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells

References

• Massaque J. TGF-β signaling transduction. Annu Rev Biochem 1998; 67: 753–791
   PubMedGoogle Scholar
• Heldin CH, Miyazona K, ten Dijke P. TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465–471
   PubMed Web of Science ®Google Scholar
• Derynck R, Zhang Y, Feng XH. Smads: Transcriptional activators of TGF-β responses. Cell 1998; 95: 737–740
   PubMed Web of Science ®Google Scholar
• Afrakhte M, Moren A, Jossan S, Itoh S, Westermark B, et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun 1998; 1: 260–1266
   Google Scholar
• Von Gersdorff G, Susztak K, Rezvani F, Bitzer M, Liang D, Bottinger EP. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor-β. J Biol Chem 2000; 275: 11320–11326
   PubMed Web of Science ®Google Scholar
• Nagarajan RP, Zhang J, Li W, Chen Y. Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J Biol Chem 1999; 274: 33412–33418
   PubMed Web of Science ®Google Scholar
• Ulloa L, Doody J, Massaque J. Inhibition of transforming growth factor-β/SMAD signaling by the interferon-γ/STAT pathway. Nature 1999; 397: 710–713
   PubMed Web of Science ®Google Scholar
• Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Bottinger EP. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev 2000; 14: 187–197
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997; 9: 180–186
   PubMed Web of Science ®Google Scholar
• Cocolakis E, Lemay S, Ali S, Lebron JJ. The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem 2001; 276: 18430–18436
   PubMed Web of Science ®Google Scholar
• Verma A, Deb KD, Sassano A, Udin S, Varga J, Wickrema A, Palantanias LC. Activation of the p38 mitogen-activated protein kinase mediates the suppressive effect of type I interferons and transforming growth factor-β on normal hematopoiesis. J Biol Chem 2002; 277: 7726–7735
   PubMed Web of Science ®Google Scholar
• Mulder KM. Role of Ras and Mapks in TGF-beta signaling. Cytokine Growth factor Rev 2000; 1: 23–35
   Google Scholar
• Fortunel N, Hatzfeld A, Hatzfeld J. Transforming growth factor-β: Pleiotropic role in the regulation of hematopoiesis. Blood 2000; 96: 2022–2036
   PubMed Web of Science ®Google Scholar
• Ruscetti FW, Bartelmez SH. Transforming growth factor-β, Pleiotropic regulator of hematopoietic stem cells: Potential physiological and clinical relevanc. Int J Hematol 2001; 74: 18–25
   PubMedGoogle Scholar
• Krystal G, Lam V, Dragowska W, et al. Transforming growth actor-β1 is an inducer of erythroid differentiation. J Exp Med 1994; 180: 851–860
   PubMed Web of Science ®Google Scholar
• Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW. Neutralization of autocrine transforming growth factor-β in human cord blood CD34+CD38−Lin− cells promotes stem cell factor-mediated erythropoietin-independent early erythroid progenitors development and reduces terminal differentiation. Stem Cells 2003; 21: 557–567
   PubMed Web of Science ®Google Scholar
• Kuter DJ, Gminski DM, Rosenberg RD. Transforming growth factor beta inhibits megakaryocyte growth and endomitosis. Blood 1992; 79: 619–626
   PubMed Web of Science ®Google Scholar
• Kalina U, Koschieder S, Hofmann WK, Wagner S, Kauschat D, Ottmann OG. Transforming growth factor-β1 interferes with thrombopoietin-induced signal transduction in megakaryoblastic and erythroleukemic cells. Exp Hematol 2001; 29: 602–608
   PubMedGoogle Scholar
• Shav-Tal Y, Zipori D. The role of activin A in regulation of hemopoiesis. Stem Cells 2002; 20: 493–500
   PubMed Web of Science ®Google Scholar
• Shiozaki M, Sakai R, Tabuchi M, Nakamura T, Sugino K, Sugino H, et al. Evidence for the participation of endogenous activin A/erythrodifferentiation factor in the regulation of erythropoiesis. PNAS 1992; 89: 1553–1556
   PubMedGoogle Scholar
• McGuckin CP, Forraz N, Liu WM. Diaminofluorene stain detects erythroid differentiation in immature haemopoietic cells treated with EPO, IL-3, SCF, TGF beta 1. MIP-1 alpha and IFN gamma. Eur J Haematol 2003; 70: 106–114
   PubMedGoogle Scholar
• Chegini N, Luo X, Ding L, Ripley D. The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol 2003; 209: 9–16
   PubMed Web of Science ®Google Scholar
• Witt O, Sand K, Pekrun A. Butyrate-induced erythroid differentiation of human K562 cells involoves inhibition of ERK and activation of p 38 MAP kinase pathways. Blood 2000; 95: 2391–2396
   PubMed Web of Science ®Google Scholar
• Park J, Choi H, Jeong J, Han J, Kim I. Involvement of p38 kinase in hydroxyurea-induced differentiation of K562 cell. Cell Growth  & Differentiation 2001; 12: 481–486
   PubMedGoogle Scholar
• Racke RK, Lewandowska K, Goueli S, Goldfarb AN. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem 1997; 272: 23366–23370
   PubMed Web of Science ®Google Scholar
• Rouyez MC, Boucheron C, Gisselbrecht S, Dusanter-Fourt I, Porteu F. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway. Mol Cell Biol 1997; 17: 4991–5000
   PubMed Web of Science ®Google Scholar
• Herrera R, Hubbell S, Decker S, Pertuzzeli L. A role for the MEK/MAPK pathway in PMA-induced cell cycle arrest: Modulation of megakaryocytic differentiation of K562 cells. Exp Cell Res 1998; 228: 407–414
   Google Scholar
• Kretzschmar M, Doody J, Timokhina I, Massaque J. A mechanism of repression of TGF-β/Smad signaling by oncogenic Ras. Genes Dev 1999; 13: 804–816
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng XH, Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 1998; 394: 909–913
   PubMed Web of Science ®Google Scholar
• Engel ME, McDonnell MA, Law BK, Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 1999; 274: 37413–37420
   PubMed Web of Science ®Google Scholar
• de Caestecker MP, Ester P, Roberts AB. Role of transforming growth factor-β signaling in cancer. J Natl Cancer Inst 2000; 92: 1388–1402
   PubMed Web of Science ®Google Scholar
• Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H. Involvement of p38 mitogen-activated- protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 1999; 274: 27161–27167
   PubMed Web of Science ®Google Scholar
• Kitamura K, Aota S, Sakamoto R, Yoshikawa S, Okazaki K. Smad7 selectively interferes with different pathways of activin signaling and inhibit erythroid leukemia cell differentiation. Blood 2000; 95: 3371–3379
   PubMedGoogle Scholar
• Ikezoe T, Takeuchi S, Kamioka M, Daibata M, Kubonishi I, Taguchi H, Miyoshi I. Analysis of the Smad2 gene in hematological malignancies. Leukemia 1998; 12: 94–95
   PubMedGoogle Scholar
• Masuya M, Kita K, Shimizu N, Ohishi K, Katayama N, Sekine T, et al. Biologic characteristics of acute leukemia and myelodysplastic syndrome. Blood 1993; 81: 3388–3394
   PubMed Web of Science ®Google Scholar
• Edlund S, Bu S, Schuster N, Apenstorm P, Heuchel R, Heldin NE, et al. Transforming growth factor-β1 (TGF-β)-induced apoptosis of prostate cancer cells involves Smad 7-dependent activation of p38 by TGF-β-activated kinase 1 and mitogen-activated protein kinase kinase3. Mol Biol Cell 2003; 14: 529–544
   PubMed Web of Science ®Google Scholar
• Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, et al. Evidence for the role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem 2001; 276: 36797–36803
   PubMed Web of Science ®Google Scholar
• Rojnuckarin P, Drachman JG, Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: Role in endomitosis. Blood 1995; 85: 402–413
   PubMedGoogle Scholar
• Guerriero R, Parolini I, Testa U, et al. Inhibition of Tpo-induced MEK or m TOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes. J Cell Sci 2006; 119: 744–752
   PubMed Web of Science ®Google Scholar